Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

NOREVELL INHALATION ANAESTHETIC LIQUID 100% [SIN16819P]

Active ingredients: SEVOFLURANE

View product's general information
Last updated on 9 October 2026

Product Info

NOREVELL INHALATION ANAESTHETIC LIQUID 100%

[SIN16819P]

Product information

Active Ingredient and Strength

SEVOFLURANE - 100%

Dosage Form

INHALANT

Manufacturer and Country

PT. NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA REP OF

Registration Number

SIN16819P

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

N01AB08

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

INDICATIONS
Sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Dosing

DOSAGE AND ADMINISTRATION
Vaporizer specially calibrated for use with Sevoflurane should be used so that the concentration delivered can be accurately controlled. MAC (minimum alveolar concentration) values for Sevoflurane decrease with age and with the addition of nitrous oxide. The table below indicates average MAC values for different age groups.

Norevell Dosage Table 1



Premedication: Premedication should be selected according to the need of the individual patient, and at the direction of the anesthetist. The use of anticholinergic drugs is a matter of choice.

Induction: Anaesthesia can be induced in adults and children with Sevoflurane. Dosage should be individualized and titrated to the desired effect according to the patient’s age and clinical status. A short acting Barbiturate or other intravenous induction agent may be administered followed by inhalation of Sevoflurane. Induction with Sevoflurane may be achieved in oxygen or in combination with oxygen-nitrous oxide mixtures. In adults inspired concentrations of up to 5% Sevoflurane usually produce surgical anaesthesia in less than 2 minutes.
In children, inspired concentrations of up to 7 % Sevoflurane usually produce surgical anaesthesia in less than 2 minutes.

Maintenance: Surgical levels of anesthesia can usually be achieve concentrations of 0.5 – 3% Sevoflurane with or without the concomitant use nitrous oxide.

Elderly: As with other inhalation agents, lesser concentrations of Sevoflurane are normally required to maintain surgical anesthesia (see MAC values).

Emergence: Emergence times are generally short following Sevoflurane anesthesia. Therefore, patients may require early post-operative pain relief.

Contraindications

CONTRAINDICATIONS
Sevoflurane should be used in patients with known or suspected sensitivity to Sevoflurane or to other halogenated inhalational anaesthetics (e.g. history of hepatotoxicity, usually including elevated liver enzymes, fever, leukocytosis and/or eosinophilia temporally related to anaesthesia with one of these agents).
Sevoflurane is also contraindicated in patients with known or suspected genetic susceptibility to malignant hypherthermia.